What is Diphenhydramine?
Diphenhydramine is a sedating antihistamine. This article refers to Spanish Soñodor difenhidramina 50 mg tablets for temporary insomnia. It does not establish equivalent ingredients, doses or dispensing status for other brands or countries.
How does Diphenhydramine work?
It blocks histamine H1 receptors and has anticholinergic effects. Sedation may help with temporary sleeplessness but can also impair attention and coordination the next day. Repeated use is not a solution for persistent insomnia; avoid assuming a fixed time to sleep or a safe driving interval.
Who is Diphenhydramine for?
The reference product treats temporary insomnia. Persistent or worsening sleep problems need medical assessment, including possible underlying causes. Older adults are more susceptible to anticholinergic effects, dizziness and confusion. The label requires medical advice for use below 18 years; safety and efficacy below 12 years are not established. This information does not change platform eligibility.
Dosage
Reference for Soñodor tablets only; follow the leaflet and professional advice.
| Group | Dose | Duration |
|---|---|---|
| Adults | 50 mg once daily, 20–30 minutes before bedtime | No more than 7 days without consulting a doctor |
Do not exceed the dose or combine with another medicine containing diphenhydramine. Liver disease and older age require particular assessment. Do not take an extra dose to compensate for a missed one.
Side effects
Drowsiness, dizziness, confusion, dry mouth, blurred vision, constipation and difficulty urinating can occur. The reference label does not assign a reliable numerical frequency to each of these effects. Older people may be particularly affected.
Seek urgent help for severe allergic symptoms, breathing difficulty, marked confusion, hallucinations or suspected overdose. An overdose can cause serious anticholinergic and cardiac effects. Do not induce vomiting yourself. This list is not exhaustive.
Diphenhydramine vs alternatives
For chronic insomnia, the European Insomnia Guideline recommends cognitive behavioural therapy for insomnia (CBT-I) first. Medicine choice requires an individual assessment; this table is not a ranking of safety or effectiveness.
| Option | Key distinction |
|---|---|
| Diphenhydramine | Sedating antihistamine; not recommended by the guideline for chronic insomnia |
| Circadin | Prolonged-release melatonin with a specific licensed age group and indication |
| Lormetazepam | Benzodiazepine; dependence and withdrawal risks |
| Zolpidem or zopiclone | Hypnotics; dependence, complex sleep behaviours and next-day impairment risks |
Products and formulations have separate labels. Do not substitute or combine them yourself.
Online assessment for Diphenhydramine
Prescrivia is a technology intermediary connecting patients with independent doctors and licensed pharmacies. It does not provide medical services, prescribe, employ doctors, sell or dispense medicines.
- Health assessment: Provide your symptoms, medical history and all current medicines for independent clinical assessment.
- Doctor review: An independent doctor decides whether any treatment is appropriate. Prescrivia does not guarantee that a prescription will be issued.
- Pharmacy responsibility: Any lawful dispensing is the responsibility of a licensed pharmacy, subject to the applicable prescription and national rules. This article does not establish product availability or a right to delivery.
In Spain, distance sale of prescription medicines is prohibited under Article 3.5 of Royal Legislative Decree 1/2015. An online assessment does not remove this restriction. Access depends on the specific product and jurisdiction.
Important safety information
Do not use the reference product with allergy to its ingredients, asthma, glaucoma, emphysema or chronic breathing problems, or difficulty urinating due to prostate enlargement. Do not use during pregnancy or breastfeeding.
Tell a doctor or pharmacist about liver disease and all medicines. Alcohol and other sedatives increase impairment. Anticholinergic medicines and other antihistamines can add adverse effects; MAO inhibitors can prolong and intensify anticholinergic effects. Do not combine without professional assessment.
Do not drive or use dangerous machinery during treatment. Sleeping through the night does not guarantee unimpaired performance the following day.
Sources
- AEMPS: Soñodor difenhidramina 50 mg, ficha técnica
- European Insomnia Guideline 2023 (ESRS)
- BOE: Real Decreto Legislativo 1/2015, artículo 3.5
The update date records an editorial edit, not a clinical review. This information does not replace the product leaflet or individual advice from a qualified healthcare professional.
Frequently asked questions
- What is diphenhydramine used for?
- The Spanish reference product Soñodor difenhidramina treats temporary insomnia. Other brands or formulations need their own label; persistent sleep problems need assessment.
- How does it help with sleep?
- It blocks histamine H1 receptors and causes sedation. Benefit is not guaranteed and it can also impair attention and coordination.
- Can it affect me the next day?
- Yes. Drowsiness and impaired coordination can persist. Do not drive or use dangerous machinery during treatment.
- Can I take it every night?
- Do not use Soñodor for more than 7 days without consulting a doctor. Chronic insomnia needs assessment; the European guideline does not recommend antihistamines for chronic insomnia.
- Who should not take it?
- The reference product must not be used with asthma, glaucoma, chronic breathing problems, prostate-related difficulty urinating, allergy to its components, pregnancy or breastfeeding. Ask a professional about your circumstances.
Intermediary notice: Prescrivia connects patients with independent doctors and licensed pharmacies. We do not provide medical advice, employ doctors, or sell medicines. All medical decisions are made by independent healthcare professionals, and prescription-only medicines require a valid prescription. Treatment is not guaranteed — whether a prescription is issued depends on an independent doctor's clinical assessment.
Current review status is not yet confirmed. Enable JavaScript to load current review records.